The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including insulin, after a two-year investigation ...
Investing.com - The Federal Trade Commission (FTC) is gearing up to sue the top three pharmacy-benefit managers (PBMs) over their strategies for negotiating drug prices, including insulin.
The Federal Trade Commission plans to sue the three largest pharmacy benefit managers in the country over practices that have kept drug prices artificially high, according to new reports from the ...
The Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health — the three largest pharmacy-benefit managers — over their tactics for negotiating prices for drugs including ...
WASHINGTON, DC: Federal Trade Commission Chair Lina Khan speaks during a discussion on antitrust ... [+] reforms at the Brookings Institution October 4, 2023. The FTC issued an interim report on ...
The Federal Trade Commission will sue three of the largest pharmacy benefit managers after the agency released a report alleging the companies—which manage roughly 80% of prescriptions in the U ...
Just one day after issuing a report blasting pharmacy benefit managers for their business practices and focus on consolidation and vertical integration, ... FTC to sue PBMs over drug pricing tactics ...
Investing.com - The Federal Trade Commission (FTC) is gearing up to sue the top three pharmacy-benefit managers (PBMs) over their strategies for negotiating drug prices, including insulin. This ...